English
简体中文
Total: £ 56.28
Published Date: 2026-04-10 | Pages: 112 | Tables: 114 | Pharma & Healthcare
The global Favipiravir market was valued at US$ 32.29 million in 2025 and is anticipated to reach US$ 5.83 million by 2032, at a CAGR of -22.0% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Favipiravir competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Favipiravir, sold under the brand name Avigan, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections. Like the experimental antiviral drugs (T-1105 and T-1106), it is a pyrazinecarboxamide derivative. It is being developed and manufactured by Toyama Chemical (Fujifilm group) and was approved for medical use in Japan in 2014. In 2016, Fujifilm licensend API for it to Zhejiang Hisun Pharmaceutical Co. of China. It became a generic drug in 2019.
The Favipiravir market has witnessed accelerated growth primarily due to the global urgency for effective antiviral therapies during outbreaks such as COVID-19. Its broad-spectrum activity against RNA viruses makes it a valuable candidate in pandemic preparedness plans. Several countries have approved Favipiravir for emergency or conditional use during viral outbreaks, boosting its visibility and adoption. Moreover, the drug's oral administration route offers ease of distribution and use, particularly in low-resource settings where intravenous treatments are less feasible. Continued investment in antiviral drug research, government stockpiling programs, and the rising incidence of emerging infectious diseases are expected to sustain demand for Favipiravir and similar oral antivirals in the foreseeable future.
Despite its potential, the Favipiravir market faces significant challenges. Clinical data regarding its efficacy for diseases beyond influenza, especially COVID-19, remains mixed, which has led to varied regulatory responses across different countries. Concerns over side effects such as teratogenicity limit its use among certain patient groups, particularly pregnant women. Additionally, the presence of more effective or better-studied antiviral drugs—like remdesivir, molnupiravir, and Paxlovid—creates intense competition in the antiviral space. Intellectual property issues and varying manufacturing standards across countries also affect the consistency of Favipiravir supply and global acceptance, complicating its market expansion.
In the global Favipiravir market, ChemRar Group, Glenmark, Fujifilm, Dr. Reddy, R-Pharma are the key players. The global 5 Largest Favipiravir Players account for 70% market share by revenue. India hold a key market revenue share of the Favipiravir market which account for 73%. The classification of Favipiravir includes Brand Drug and Generic Drug. Brand Drug accounted for a share of 16% in the global Favipiravir market.
This report delivers a comprehensive overview of the global Favipiravir market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Favipiravir. The Favipiravir market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Favipiravir market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Favipiravir manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Cipla
Lupin
Sun Pharma
Hisun Pharm
Segment by Type
Brand Drug
Generic Drug
by Application
Influenza Viruses
COVID-19
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Favipiravir manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Favipiravir sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Favipiravir Market Overview
1.1 Product Definition
1.2 Favipiravir by Type
1.2.1 Global Favipiravir Market Value by Type: 2025 vs 2032
1.2.2 Brand Drug
1.2.3 Generic Drug
1.3 Favipiravir by Application
1.3.1 Global Favipiravir Market Value by Application: 2025 vs 2032
1.3.2 Influenza Viruses
1.3.3 COVID-19
1.3.4 Others
1.4 Global Favipiravir Market Size Estimates and Forecasts
1.4.1 Global Favipiravir Revenue 2021–2032
1.4.2 Global Favipiravir Sales 2021–2032
1.4.3 Global Favipiravir Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Favipiravir Market Competition by Manufacturers
2.1 Global Favipiravir Sales Market Share by Manufacturers (2021–2026)
2.2 Global Favipiravir Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Favipiravir Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Favipiravir, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Favipiravir, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Favipiravir, Product Types and Applications
2.7 Global Key Manufacturers of Favipiravir, Date of Entry into the Industry
2.8 Global Favipiravir Market Competitive Situation and Trends
2.8.1 Global Favipiravir Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Favipiravir Players Market Share by Revenue
2.8.3 Global Favipiravir Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Favipiravir Market Scenario by Region
3.1 Global Favipiravir Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Favipiravir Sales by Region: 2021–2032
3.2.1 Global Favipiravir Sales by Region: 2021–2026
3.2.2 Global Favipiravir Sales by Region: 2027–2032
3.3 Global Favipiravir Revenue by Region: 2021–2032
3.3.1 Global Favipiravir Revenue by Region: 2021–2026
3.3.2 Global Favipiravir Revenue by Region: 2027–2032
3.4 North America Favipiravir Market Facts & Figures by Country
3.4.1 North America Favipiravir Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Favipiravir Sales by Country (2021–2032)
3.4.3 North America Favipiravir Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Favipiravir Market Facts & Figures by Country
3.5.1 Europe Favipiravir Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Favipiravir Sales by Country (2021–2032)
3.5.3 Europe Favipiravir Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Favipiravir Market Facts & Figures by Region
3.6.1 Asia Pacific Favipiravir Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Favipiravir Sales by Region (2021–2032)
3.6.3 Asia Pacific Favipiravir Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Favipiravir Market Facts & Figures by Country
3.7.1 Latin America Favipiravir Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Favipiravir Sales by Country (2021–2032)
3.7.3 Latin America Favipiravir Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Favipiravir Market Facts & Figures by Country
3.8.1 Middle East and Africa Favipiravir Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Favipiravir Sales by Country (2021–2032)
3.8.3 Middle East and Africa Favipiravir Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Favipiravir Sales by Type (2021–2032)
4.1.1 Global Favipiravir Sales by Type (2021–2026)
4.1.2 Global Favipiravir Sales by Type (2027–2032)
4.1.3 Global Favipiravir Sales Market Share by Type (2021–2032)
4.2 Global Favipiravir Revenue by Type (2021–2032)
4.2.1 Global Favipiravir Revenue by Type (2021–2026)
4.2.2 Global Favipiravir Revenue by Type (2027–2032)
4.2.3 Global Favipiravir Revenue Market Share by Type (2021–2032)
4.3 Global Favipiravir Price by Type (2021–2032)
5 Segment by Application
5.1 Global Favipiravir Sales by Application (2021–2032)
5.1.1 Global Favipiravir Sales by Application (2021–2026)
5.1.2 Global Favipiravir Sales by Application (2027–2032)
5.1.3 Global Favipiravir Sales Market Share by Application (2021–2032)
5.2 Global Favipiravir Revenue by Application (2021–2032)
5.2.1 Global Favipiravir Revenue by Application (2021–2026)
5.2.2 Global Favipiravir Revenue by Application (2027–2032)
5.2.3 Global Favipiravir Revenue Market Share by Application (2021–2032)
5.3 Global Favipiravir Price by Application (2021–2032)
6 Key Companies Profiled
6.1 ChemRar Group
6.1.1 ChemRar Group Company Information
6.1.2 ChemRar Group Description and Business Overview
6.1.3 ChemRar Group Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 ChemRar Group Favipiravir Product Portfolio
6.1.5 ChemRar Group Recent Developments/Updates
6.2 Glenmark
6.2.1 Glenmark Company Information
6.2.2 Glenmark Description and Business Overview
6.2.3 Glenmark Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Glenmark Favipiravir Product Portfolio
6.2.5 Glenmark Recent Developments/Updates
6.3 Fujifilm
6.3.1 Fujifilm Company Information
6.3.2 Fujifilm Description and Business Overview
6.3.3 Fujifilm Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Fujifilm Favipiravir Product Portfolio
6.3.5 Fujifilm Recent Developments/Updates
6.4 Dr. Reddy
6.4.1 Dr. Reddy Company Information
6.4.2 Dr. Reddy Description and Business Overview
6.4.3 Dr. Reddy Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Dr. Reddy Favipiravir Product Portfolio
6.4.5 Dr. Reddy Recent Developments/Updates
6.5 R-Pharma
6.5.1 R-Pharma Company Information
6.5.2 R-Pharma Description and Business Overview
6.5.3 R-Pharma Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 R-Pharma Favipiravir Product Portfolio
6.5.5 R-Pharma Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Company Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Cipla Favipiravir Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Lupin
6.7.1 Lupin Company Information
6.7.2 Lupin Description and Business Overview
6.7.3 Lupin Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Lupin Favipiravir Product Portfolio
6.7.5 Lupin Recent Developments/Updates
6.8 Sun Pharma
6.8.1 Sun Pharma Company Information
6.8.2 Sun Pharma Description and Business Overview
6.8.3 Sun Pharma Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Sun Pharma Favipiravir Product Portfolio
6.8.5 Sun Pharma Recent Developments/Updates
6.9 Hisun Pharm
6.9.1 Hisun Pharm Company Information
6.9.2 Hisun Pharm Description and Business Overview
6.9.3 Hisun Pharm Favipiravir Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hisun Pharm Favipiravir Product Portfolio
6.9.5 Hisun Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Favipiravir Industry Chain Analysis
7.2 Favipiravir Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Favipiravir Production Mode & Process Analysis
7.4 Favipiravir Sales and Marketing
7.4.1 Favipiravir Sales Channels
7.4.2 Favipiravir Distributors
7.5 Favipiravir Customer Analysis
8 Favipiravir Market Dynamics
8.1 Favipiravir Industry Trends
8.2 Favipiravir Market Drivers
8.3 Favipiravir Market Challenges
8.4 Favipiravir Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Favipiravir Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Favipiravir Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Favipiravir Market Competitive Situation by Manufacturers in 2025
Table 4. Global Favipiravir Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Favipiravir Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Favipiravir Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Favipiravir Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Favipiravir Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Favipiravir, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Favipiravir, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Favipiravir, Product Types and Applications
Table 12. Global Key Manufacturers of Favipiravir, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Favipiravir Companies by Tier (Tier 1, Tier 2, Tier 3), based on Favipiravir Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Favipiravir Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Favipiravir Sales by Region (K Units), 2021–2026
Table 18. Global Favipiravir Sales Market Share by Region (2021–2026)
Table 19. Global Favipiravir Sales by Region (K Units), 2027–2032
Table 20. Global Favipiravir Sales Market Share by Region (2027–2032)
Table 21. Global Favipiravir Revenue by Region (US$ Million), 2021–2026
Table 22. Global Favipiravir Revenue Market Share by Region (2021–2026)
Table 23. Global Favipiravir Revenue by Region (US$ Million), 2027–2032
Table 24. Global Favipiravir Revenue Market Share by Region (2027–2032)
Table 25. North America Favipiravir Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Favipiravir Sales by Country (K Units), 2021–2026
Table 27. North America Favipiravir Sales by Country (K Units), 2027–2032
Table 28. North America Favipiravir Revenue by Country (US$ Million), 2021–2026
Table 29. North America Favipiravir Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Favipiravir Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Favipiravir Sales by Country (K Units), 2021–2026
Table 32. Europe Favipiravir Sales by Country (K Units), 2027–2032
Table 33. Europe Favipiravir Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Favipiravir Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Favipiravir Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Favipiravir Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Favipiravir Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Favipiravir Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Favipiravir Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Favipiravir Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Favipiravir Sales by Country (K Units), 2021–2026
Table 42. Latin America Favipiravir Sales by Country (K Units), 2027–2032
Table 43. Latin America Favipiravir Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Favipiravir Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Favipiravir Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Favipiravir Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Favipiravir Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Favipiravir Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Favipiravir Revenue by Country (US$ Million), 2027–2032
Table 50. Global Favipiravir Sales (K Units) by Type (2021–2026)
Table 51. Global Favipiravir Sales (K Units) by Type (2027–2032)
Table 52. Global Favipiravir Sales Market Share by Type (2021–2026)
Table 53. Global Favipiravir Sales Market Share by Type (2027–2032)
Table 54. Global Favipiravir Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Favipiravir Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Favipiravir Revenue Market Share by Type (2021–2026)
Table 57. Global Favipiravir Revenue Market Share by Type (2027–2032)
Table 58. Global Favipiravir Price (US$/Unit) by Type (2021–2026)
Table 59. Global Favipiravir Price (US$/Unit) by Type (2027–2032)
Table 60. Global Favipiravir Sales (K Units) by Application (2021–2026)
Table 61. Global Favipiravir Sales (K Units) by Application (2027–2032)
Table 62. Global Favipiravir Sales Market Share by Application (2021–2026)
Table 63. Global Favipiravir Sales Market Share by Application (2027–2032)
Table 64. Global Favipiravir Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Favipiravir Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Favipiravir Revenue Market Share by Application (2021–2026)
Table 67. Global Favipiravir Revenue Market Share by Application (2027–2032)
Table 68. Global Favipiravir Price (US$/Unit) by Application (2021–2026)
Table 69. Global Favipiravir Price (US$/Unit) by Application (2027–2032)
Table 70. ChemRar Group Company Information
Table 71. ChemRar Group Description and Business Overview
Table 72. ChemRar Group Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. ChemRar Group Favipiravir Product
Table 74. ChemRar Group Recent Developments/Updates
Table 75. Glenmark Company Information
Table 76. Glenmark Description and Business Overview
Table 77. Glenmark Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Glenmark Favipiravir Product
Table 79. Glenmark Recent Developments/Updates
Table 80. Fujifilm Company Information
Table 81. Fujifilm Description and Business Overview
Table 82. Fujifilm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Fujifilm Favipiravir Product
Table 84. Fujifilm Recent Developments/Updates
Table 85. Dr. Reddy Company Information
Table 86. Dr. Reddy Description and Business Overview
Table 87. Dr. Reddy Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Dr. Reddy Favipiravir Product
Table 89. Dr. Reddy Recent Developments/Updates
Table 90. R-Pharma Company Information
Table 91. R-Pharma Description and Business Overview
Table 92. R-Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. R-Pharma Favipiravir Product
Table 94. R-Pharma Recent Developments/Updates
Table 95. Cipla Company Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Cipla Favipiravir Product
Table 99. Cipla Recent Developments/Updates
Table 100. Lupin Company Information
Table 101. Lupin Description and Business Overview
Table 102. Lupin Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. Lupin Favipiravir Product
Table 104. Lupin Recent Developments/Updates
Table 105. Sun Pharma Company Information
Table 106. Sun Pharma Description and Business Overview
Table 107. Sun Pharma Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Sun Pharma Favipiravir Product
Table 109. Sun Pharma Recent Developments/Updates
Table 110. Hisun Pharm Company Information
Table 111. Hisun Pharm Description and Business Overview
Table 112. Hisun Pharm Favipiravir Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Hisun Pharm Favipiravir Product
Table 114. Hisun Pharm Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Favipiravir Distributors List
Table 118. Favipiravir Customers List
Table 119. Favipiravir Market Trends
Table 120. Favipiravir Market Drivers
Table 121. Favipiravir Market Challenges
Table 122. Favipiravir Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
Table 126. Authors List of This Report
List of Figures
Figure 1. Product Picture of Favipiravir
Figure 2. Global Favipiravir Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Favipiravir Market Share by Type: 2025 & 2032
Figure 4. Brand Drug Product Picture
Figure 5. Generic Drug Product Picture
Figure 6. Global Favipiravir Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Favipiravir Market Share by Application: 2025 & 2032
Figure 8. Influenza Viruses
Figure 9. COVID-19
Figure 10. Others
Figure 11. Global Favipiravir Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 12. Global Favipiravir Market Size (US$ Million), 2021–2032
Figure 13. Global Favipiravir Sales (K Units), 2021–2032
Figure 14. Global Favipiravir Average Price (US$/Unit), 2021–2032
Figure 15. Favipiravir Report Years Considered
Figure 16. Favipiravir Sales Share by Manufacturers in 2025
Figure 17. Global Favipiravir Revenue Share by Manufacturers in 2025
Figure 18. Top 5 and Top 10 Global Favipiravir Players: Market Share by Revenue in Favipiravir in 2025
Figure 19. Favipiravir Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 20. Global Favipiravir Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 21. North America Favipiravir Sales Market Share by Country (2021–2032)
Figure 22. North America Favipiravir Revenue Market Share by Country (2021–2032)
Figure 23. United States Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 24. Canada Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Europe Favipiravir Sales Market Share by Country (2021–2032)
Figure 26. Europe Favipiravir Revenue Market Share by Country (2021–2032)
Figure 27. Germany Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 28. France Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. U.K. Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. Italy Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Russia Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Asia Pacific Favipiravir Sales Market Share by Region (2021–2032)
Figure 33. Asia Pacific Favipiravir Revenue Market Share by Region (2021–2032)
Figure 34. China Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 35. Japan Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. South Korea Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. India Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. Australia Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Taiwan Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Indonesia Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Thailand Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Malaysia Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America Favipiravir Sales Market Share by Country (2021–2032)
Figure 44. Latin America Favipiravir Revenue Market Share by Country (2021–2032)
Figure 45. Mexico Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Favipiravir Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Favipiravir Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Favipiravir Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Favipiravir by Type (2021–2032)
Figure 54. Global Revenue Market Share of Favipiravir by Type (2021–2032)
Figure 55. Global Favipiravir Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Favipiravir by Application (2021–2032)
Figure 57. Global Revenue Market Share of Favipiravir by Application (2021–2032)
Figure 58. Global Favipiravir Price (US$/Unit) by Application (2021–2032)
Figure 59. Favipiravir Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
